Time to seizure occurrence and damage in PROFILE,a multi-ethnic systemic lupus erythematosus cohort

Abstract

The objective of this study was to determine risk factors predicting seizures and damage caused by seizures in a multi-ethnic systemic lupus erythematosus cohort (PROFILE) that includes systemic lupus erythematosus patients (n = 1295) from five different US institutions. Only patients with seizures after systemic lupus erythematosus diagnosis (incident) were included in the analyses of clinical seizures (80/1295, 6.2%), but all patients (prevalent and incident) were included in the analyses of damage caused by seizures (51/1295, 3.9%). We examined socioeconomic–demographic, clinical, and genetic variables predictive of clinical seizures and damage from seizures by Cox proportional hazard ratios (HR) and 95% confidence intervals (CI). Independent predictors of a shorter time to the occurrence of clinical seizures were younger age (HR = 1.0; 95% CI 0.9–1.0), having Hispanic-Texan ethnicity (HR = 2.7; 95% CI 1.3–5.7) or African-American ethnicity (HR = 1.8; 95% CI 1.0–3.1), and the previous occurrence of a cerebrovascular accident (HR = 3.3; 95% CI 1.6–7.1) or an episode of psychosis (HR = 2.4; 95% CI 1.1–5.0), whereas the previous occurrence of photosensitivity (HR = 0.5; 95% CI 0.3–0.9) was the only independent predictor of a longer time to the occurrence of clinical seizures. Independent predictors of a shorter time to the occurrence of damage caused by seizures were younger age (HR = 1.0; 95% CI 0.9–1.0), male gender (HR = 2.4; 95% CI 1.1–5.4), and the occurrence of a previous cerebrovascular accident (HR = 2.7; 95% CI 1.0–7.0) or an episode of psychosis (HR = 4.7; 95% CI 2.3–9.9). No allele from the candidate genes examined (HLA-DRB1, HLA-DQB1, FCGR2A, FCGR3A, or FCG3B) predicted clinical seizures or damage caused by seizures.

Keywords

seizures lupus PROFILE

Get full access to this article

View all access options for this article.

References

1 Ainiala H Hietaharju A Loukkola J . Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001; 45: 419 – 423 .

2 Brey RL Holliday SL Saklad AR . Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 1214 – 1220 .

3 Hanly JG McCurdy G Fougere L Douglas JA Thompson K . Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31: 2156 – 2162 .

4 Sanna G Bertolaccini ML Cuadrado MJ . Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985 – 992 .

5 Sibbitt WL Brandt JR Johnson CR . The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29: 1536 – 1542 .

6 Hanly JG Urowitz MB Sanchez-Guerrero J . Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007; 56: 265 – 273 .

7 Mikdashi J Krumholz A Handwerger B . Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 2005; 64: 2102 – 2107 .

8 Appenzeller S Cendes F Costallat LT . Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808 – 1812 .

9 Nath SK Kilpatrick J Harley JB . Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794 – 800 .

10.

10 Croker JA Kimberly RP . SLE: challenges and candidates in human disease. Trends Immunol 2005; 26: 580 – 586 .

11.

11 Croker JA Kimberly RP . Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529 – 537 .

12.

12 Graham RR Kozyrev SV Baechler EC . A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550 – 555 .

13.

13 Alarcón GS McGwin G Petri M . Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006; 3: e396 .

14.

14 Turnbull J; Lohi H; Kearney JA; . Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 2005; 14: 2491–2500.

15.

15 Ferraro TN Dlugos DJ Buono RJ . Role of genetics in the diagnosis and treatment of epilepsy. Expert Rev Neurother 2006; 6: 1789 – 1800 .

16.

16 Berkovic SF Harkin L McMahon JM . De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006; 5: 488 – 492 .

17.

17 Alarcón GS McGwin G Petri M Reveille JD Ramsey-Goldman R Kimberly RP . Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95 – 101 .

18.

18 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classifcation of systemic lupus erythematosus. Arthritis Rheum 1998; 41: 751 .

19.

19 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271 – 1277 .

20.

20 Gladman DD Goldsmith CH Urowitz MB . The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000; 27: 373 – 376 .

21.

21 Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 .

22.

22 Gladman DD Ginzler E Goldsmith C . The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996; 39: 363 – 369 .

23.

23 Reveille JD Durban E MacLeod-St Clair MJ . Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992; 90: 973 – 980 .

24.

24 Marsh SG; Bodmer JG; . HLA class II region nucleotide sequences, 1995. Tissue Antigens 1995; 46: 258–280.

25.

25 Edberg JC Langefeld CD Wu J . Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2132 – 2140 .

26.

26 Brooks K Fessler B Bastian H Alarcón G . Sociocultural issues in clinical research. Arthritis Care Res 2001; 45: 203 – 207 .

27.

27 Gladman DD Goldsmith CH Urowitz MB . Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 1994; 21: 1468 – 1471 .

28.

28 Liang MH Socher SA Larson MG Schur PH . Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107 – 1118 .